The Center for Technology Licensing (CTL) is Cornell University’s technology transfer office. CTL’s mission is to bring the University’s scientific discoveries, technological innovations, and medical advances to the marketplace for societal benefit and to foster new venture creation and growth to support economic development within New York State and across the nation.
The office manages a broad array of technologies for Cornell’s various campuses, including the Ithaca campus, Weill Cornell Medicine (WCM), Cornell Tech in New York City, and Cornell AgriTech in Geneva.
To bridge the gap between lab and market, business ideas, and successful startups, CTL manages the university gap funding series and works closely with the university’s incubators and accelerators to advance commercialization, new ventures, and partnerships.
Our team members are driven by the idea that the best way to fulfill our mission is born from seamless support to the research community, dedication, and expertise.
Cornell Innovation & Venture Advisors
The Cornell Innovation & Venture Advisors group (“CIVA”) is an exclusive community of experts who are provided a first look at emerging technologies and venture opportunities from Cornell University’s Center for Technology Licensing (“CTL”) and Weill Cornell’s Enterprise Innovation. They meet quarterly to attend presentations from Cornell’s promising inventors and provide feedback regarding the market opportunities and the commercialization strategies for the innovation.
CTL works diligently with Cornell researchers and innovators by bringing their inventions from the lab to the marketplace. As Cornell’s technology commercialization office, we are exploring new ways to create business opportunities, launching new ventures, and helping to commercialize Cornell technologies. Learn more about CTL’s annual activities and metrics.